Concomitant Use of Cholinesterase Inhibitors and Anticholinergics: Prevalence and Outcomes
- 22 October 2011
- journal article
- research article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 59 (11) , 2069-2076
Abstract
Objectives: To determine the extent of concomitant use of cholinesterase inhibitor ( ChI ) and anticholinergic ( ACh ) medications and the clinical consequences of dual use in a population‐based setting. Design: Retrospective cohort study. Setting: Group Health Cooperative and Kaiser Permanente C olorado. Participants: Five thousand six hundred twenty‐five adults aged 50 and older who began new use of a ChI between 2000 and 2007. Measurements: Rates and characteristics of concomitant ChI and ACh use and the association between dual use and the outcomes of death and nursing home placement (claim from a nursing home with no prior claims used as a proxy). Results: Thirty‐seven percent of ChI users also received AChs . Eleven percent of ChI users were concomitantly using two or more moderate to potent AChs . Median duration of this concomitant use was approximately 4 months, but a substantial proportion (25%) continued to use both medication classes simultaneously for longer than 12 months. In 23% of ChI users, AChs were being used at the time ChI therapy was initiated. The majority of this ACh use (77%) was not stopped once ChIs were started. No association was observed between concomitant use and risk of death or nursing home placement. Conclusion: These results should raise awareness about the prevalence and potential inappropriateness of concomitant use of ChIs and AChs and promote evaluations of practices intended to improve care standards.Keywords
This publication has 34 references indexed in Scilit:
- Cholinesterase inhibition: is there evidence for disease-modifying effects?Current Medical Research and Opinion, 2009
- Cholinesterase Inhibitors and BeyondCurrent Alzheimer Research, 2009
- Review: Donepezil in Severe Alzheimer's DiseaseAmerican Journal of Alzheimer's Disease and Other Dementias®, 2009
- Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patientsNeurological Sciences, 2009
- Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice GuidelineAnnals of Internal Medicine, 2008
- Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trialsThe Lancet Neurology, 2007
- Functional Outcomes of Drug Treatment in Alzheimer???s DiseaseDrugs & Aging, 2007
- The Concurrent Use of Anticholinergics and Cholinesterase Inhibitors: Rare Event or Common Practice?Journal of the American Geriatrics Society, 2004
- Use of Anticholinergic Medications by Older Adults with DementiaJournal of the American Geriatrics Society, 2002
- Cholinesterase Inhibition for Alzheimer DiseaseJAMA, 1998